LncRNA NORFA promotes the synthesis of estradiol and inhibits the apoptosis of sow ovarian granulosa cells through SF-1/CYP11A1 axis.

Autor: Guo, Zhennan¹ (AUTHOR), Zeng, Qiang¹ (AUTHOR), Li, Qiqi^1,2 (AUTHOR), Shan, Baosen¹ (AUTHOR), Huo, Yangan¹ (AUTHOR), Shi, Xiaoli^1,3 (AUTHOR), Li, Qifa¹ (AUTHOR), Du, Xing¹ (AUTHOR) duxing@njau.edu.cn

Publikováno v: Biology Direct. 11/10/2024, Vol. 19 Issue 1, p1-16. 16p.

Efficacy and safety of Anlotinib based neoadjuvant chemotherapy for locally advanced triple negative breast cancer (TNBC).

Autor: Ren, Kuojun^1,2 (AUTHOR), Wang, Shuhan^1,2 (AUTHOR), Ye, Tingbo¹ (AUTHOR), Zhu, Zhengzhi^1,2 (AUTHOR), Hong, Shikai^1,2 (AUTHOR), Wang, Shengying^1,2 (AUTHOR) shengywang@163.com, Liu, Jianjun^1,2 (AUTHOR) ljianjun@ustc.edu.cn

Publikováno v: BMC Cancer. 10/7/2024, Vol. 24 Issue 1, p1-8. 8p.

The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study.

Autor: de Ruijter TC; 1Division of Medical Oncology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands.; 2GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Smits KM; 1Division of Medical Oncology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands.; 2GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.; 3Department of Pathology, Maastricht University Medical Centre, Maastricht, The Netherlands., Aarts MJ; 1Division of Medical Oncology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands.; 2GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., van Hellemond IEG; 1Division of Medical Oncology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands.; 2GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Van Neste L; 2GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.; 3Department of Pathology, Maastricht University Medical Centre, Maastricht, The Netherlands., de Vries B; Department of Pathology, Zuyderland Medical Centre, Heerlen, The Netherlands., Peer PGM; 5Biostatistics, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Veeck J; 1Division of Medical Oncology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands.; 2GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., van Engeland M; 2GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.; 3Department of Pathology, Maastricht University Medical Centre, Maastricht, The Netherlands., Tjan-Heijnen VCG; 1Division of Medical Oncology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands.; 2GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

Publikováno v: Diagnostic and prognostic research [Diagn Progn Res] 2019 Oct 17; Vol. 3, pp. 20. Date of Electronic Publication: 2019 Oct 17 (Print Publication: 2019).

Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.

Autor: van Hellemond IEG; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Vriens IJH; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Peer PGM; Biostatistics, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Swinkels ACP; Clinical Research Department, Netherlands Comprehensive Cancer Organization IKNL, Utrecht, The Netherlands., Smorenburg CH; Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, The Netherlands., Seynaeve CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Sangen MJC; Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., de Graaf H; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Honkoop AH; Department of Medical Oncology, Isala Clinics, Zwolle, The Netherlands., Erdkamp FLG; Department of Medical Oncology, Zuyderland Medical Center, Sittard, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center, Heerlen, The Netherlands., de Boer M; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., de Roos WK; Department of Surgery, Gelderse Vallei Hospital, Ede, The Netherlands., Linn SC; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Imholz ALT; Department of Medical Oncology, Deventer Hospital, Deventer, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.

Publikováno v: International journal of cancer [Int J Cancer] 2019 Jul 01; Vol. 145 (1), pp. 274-283. Date of Electronic Publication: 2019 Jan 16.

Paediatric Ebstein's anomaly: how clinical presentation predicts mortality.

Autor: Geerdink LM; Department of Paediatric Cardiology, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Paediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany., Delhaas T; Department of Paediatric Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands., Helbing WA; Department of Paediatric Cardiology, Sophia Children's Hospital, Erasmus Medical Centre, Rotterdam, The Netherlands., du Marchie Sarvaas GJ; Centre for Congenital Heart Diseases, Beatrix Children's Hospital, University Medical Centre Groningen, Groningen, The Netherlands., Heide HT; Department of Paediatric Cardiology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands., Rozendaal L; Department of Paediatric Cardiology, Willem Alexander Children's Hospital, Leiden University Medical Centre, Leiden, The Netherlands., de Korte CL; Medical Ultrasound Imaging Centre, Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Peer PGM; Department of Biostatistics, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands., Kuipers IM; Department of Paediatric Cardiology, Academic Medical Centre, Amsterdam, The Netherlands., Kapusta L; Department of Paediatric Cardiology, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Paediatrics, Paediatric Cardiology Unit, Tel Aviv Sourasky Medical Centre, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Publikováno v: Archives of disease in childhood [Arch Dis Child] 2018 Sep; Vol. 103 (9), pp. 859-863. Date of Electronic Publication: 2018 Mar 22.